Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;36(10):974-8.
doi: 10.1002/humu.22838. Epub 2015 Aug 6.

GenomeConnect: matchmaking between patients, clinical laboratories, and researchers to improve genomic knowledge

Affiliations

GenomeConnect: matchmaking between patients, clinical laboratories, and researchers to improve genomic knowledge

Brianne E Kirkpatrick et al. Hum Mutat. 2015 Oct.

Abstract

As the utility of genetic and genomic testing in healthcare grows, there is need for a high-quality genomic knowledge base to improve the clinical interpretation of genomic variants. Active patient engagement can enhance communication between clinicians, patients, and researchers, contributing to knowledge building. It also encourages data sharing by patients and increases the data available for clinicians to incorporate into individualized patient care, clinical laboratories to utilize in test interpretation, and investigators to use for research. GenomeConnect is a patient portal supported by the Clinical Genome Resource (ClinGen), providing an opportunity for patients to add to the knowledge base by securely sharing their health history and genetic test results. Data can be matched with queries from clinicians, laboratory personnel, and researchers to better interpret the results of genetic testing and build a foundation to support genomic medicine. Participation is online, allowing patients to contribute regardless of location. GenomeConnect supports longitudinal, detailed clinical phenotyping and robust "matching" among research and clinical communities. Phenotype data are gathered using online health questionnaires; genotype data are obtained from genetic test reports uploaded by participants and curated by staff. GenomeConnect empowers patients to actively participate in the improvement of genomic test interpretation and clinical utility.

Keywords: data sharing; genotype/phenotype; matchmaker exchange; patient portal; patient registry.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sources of Data for Open Sharing. The sources of information for genomic databases like ClinVar are varied. GenomeConnect enables patients, who have copies of their genetic test reports and are valuable sources of rich phenotypic data, to be contributors of information.
Figure 2
Figure 2
Participant Engagement Experience in GenomeConnect. This figure highlights the process a participant undergoes to join and participate in GenomeConnect. A participant logged into their account sees which steps require their attention. They receive email notifications from GenomeConnect if there is a survey to complete or research opportunity to consider in a manner that protects their privacy. A re-linking code is maintained by GenomeConnect for controlled recontacting of participants. Participants determine if they wish to receive any invitations from researchers or participants and if they agree, they then respond individually to each request.
Figure 3
Figure 3
Bi-directional Communication in GenomeConnect. GenomeConnect maintains two-way communication with the various parties involved. For example, laboratories are notified when reports from their lab are uploaded by GenomeConnect participants, and those desiring further phenotype data are able to request further information, helping them to improve test interpretation. GenomeConnect staff maintain email communication and communication via the participant portals to alert participants to health surveys available for them to complete and notifications of others desiring contact with them. Participants maintain control over the invitations and surveys to which they respond.

References

    1. Broderick JE, Morgan DeWitt E, Rothrock N, Crane PK. Advances in Patient Reported Outcomes: the NIH PROMIS Measures. eGEMs (Generating Evidence & Methods to improve patient outcomes) 2013;1(1) Article 12. - PMC - PubMed
    1. International Human Genome Sequencing Consortium Finishing the euchromatic sequence of the human genome. Nature. 2004;431:931–945. - PubMed
    1. Lambertson K, Damiani S, Might M, Shelton R, Terry S. Participant-led matchmaking. Hum Mutat. 2015;36:xxx–yyy. - PubMed
    1. Mayo Clinic website [April 10, 2015];Mayo Medical Laboratories Interpretive Handbook. from http://www.mayomedicallaboratories.com/interpretive-guide/?alpha=C&unit_....
    1. Might M, Wilsey M. The shifting model in clinical diagnostics: how next-generation sequencing and families are altering the way rare diseases are discovered, studied, and treated. Genet Med. 2014;16(10):736–7. - PubMed

Publication types